Diagnosed with stage four triple breast cancer, a woman in Scotland and her family now raise funds so that this mother of two can participate…
Mnemo Therapeutics, a biotechnology company based in Paris, announced the completion of its €75 million ($90 million) Series A financing. The Series A financing was…
University of California, San Francisco (UCSF) researchers focusing on immunotherapies that fight cancer center their attention on emerging engineered smart immune cells can zap solid…
Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and the Garvan Institute in Australia…
An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. Reno Debets (CSO) and Dr.…
The U.S. Food and Drug Administration decided to open the Orphan Drug Designation (ODD) to an investigational drug for the treatment of patients with multiple…
IO Biotech, a Danish clinical-stage biotech venture developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology raised EUR 127 million in Series B…
A 46 year-old man residing in the Louisville, Kentucky area was given about six months to live, according to a physician’s grim forecast. With stage…
French pharmaceutical giant Sanofi has made an offer to acquire Kiadis, a clinical-stage biotech company developing what they refer to as ‘off the shelf’ natural…
Ose Immunotherapeutics will conduct a clinical trial involving up to 400 patients for an experimental COVID-19 vaccine it hopes can further help fight the global…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
